Adrian M. Seifert

1.9k total citations
37 papers, 1.4k citations indexed

About

Adrian M. Seifert is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adrian M. Seifert has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adrian M. Seifert's work include Cancer Immunotherapy and Biomarkers (12 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Adrian M. Seifert is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Gastrointestinal Tumor Research and Treatment (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Adrian M. Seifert collaborates with scholars based in Germany, United States and Austria. Adrian M. Seifert's co-authors include Andreas Krause, Wolfgang Schmidt, Alexander Natusch, Ronald P. DeMatteo, Shan Zeng, Ferdinand Rossi, Lena Seifert, Jürgen Weitz, Teresa S. Kim and Cristina R. Antonescu and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Adrian M. Seifert

34 papers receiving 1.4k citations

Peers

Adrian M. Seifert
Jong-Seok Lee South Korea
Michael J. Cavnar United States
Badreddin Edris United States
Paolo Cotzia United States
Dakeun Lee South Korea
Adrian M. Seifert
Citations per year, relative to Adrian M. Seifert Adrian M. Seifert (= 1×) peers Hans‐Michael Behrens

Countries citing papers authored by Adrian M. Seifert

Since Specialization
Citations

This map shows the geographic impact of Adrian M. Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian M. Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian M. Seifert more than expected).

Fields of papers citing papers by Adrian M. Seifert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian M. Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian M. Seifert. The network helps show where Adrian M. Seifert may publish in the future.

Co-authorship network of co-authors of Adrian M. Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian M. Seifert. A scholar is included among the top collaborators of Adrian M. Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian M. Seifert. Adrian M. Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baenke, Franziska, Ulrich Sommer, Daniela E. Aust, et al.. (2025). Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma. OncoImmunology. 14(1). 2574859–2574859.
2.
Kawaler, Emily, Ulrich Sommer, Franziska Baenke, et al.. (2025). Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. JCI Insight. 11(2).
3.
Plesca, Ioana, Charlotte Reiche, Ulrich Sommer, et al.. (2023). VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. Cancers. 15(8). 2326–2326. 10 indexed citations
4.
Seifert, Lena, Janusz von Renesse, Adrian M. Seifert, et al.. (2023). Interrupted versus continuous suture technique for biliary-enteric anastomosis: randomized clinical trial. BJS Open. 7(1). 11 indexed citations
5.
Plesca, Ioana, Iva Benešová, Ulrich Sommer, et al.. (2022). Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma. Cancers. 14(5). 1216–1216. 27 indexed citations
6.
Wong, Fang Cheng, Lena Seifert, Adrian M. Seifert, et al.. (2022). Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases. Oncogene. 41(12). 1809–1820. 26 indexed citations
7.
Plesca, Ioana, Jessica M. Gluck, Luise Müller, et al.. (2022). Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer. JCI Insight. 7(22). 17 indexed citations
8.
Baenke, Franziska, Fang Cheng Wong, Martin Schneider, et al.. (2021). Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer. Cancers. 13(6). 1351–1351. 42 indexed citations
9.
Renesse, Janusz von, Simone von Bonin, R. Schneider, et al.. (2021). Energy requirements of long-term ventilated COVID-19 patients with resolved SARS-CoV-2 infection. Clinical Nutrition ESPEN. 44. 211–217. 13 indexed citations
10.
Zhang, Jennifer Q., Benedikt Bosbach, Jennifer K. Loo, et al.. (2020). The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor. Oncogene. 39(49). 7153–7165. 9 indexed citations
11.
Medina, Benjamin D., Mengyuan Liu, Gerardo A. Vitiello, et al.. (2019). Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity. The Journal of Experimental Medicine. 216(6). 1359–1376. 22 indexed citations
12.
Santamaria‐Barria, Juan A., Shan Zeng, Jonathan B. Greer, et al.. (2019). Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells. PLoS ONE. 14(5). e0216275–e0216275. 12 indexed citations
13.
Zhang, Jennifer Q., Shan Zeng, Gerardo A. Vitiello, et al.. (2018). Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunology Research. 6(4). 434–447. 48 indexed citations
14.
Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 16(9). 1954–1966. 31 indexed citations
15.
Sorenson, Eric C., Raya Khanin, Zubin M. Bamboat, et al.. (2017). Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation. PLoS ONE. 12(5). e0176562–e0176562. 23 indexed citations
16.
Seifert, Adrian M., Shan Zeng, Jennifer Q. Zhang, et al.. (2016). PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 23(2). 454–465. 117 indexed citations
17.
Kim, Teresa S., Michael J. Cavnar, Noah A. Cohen, et al.. (2014). Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor. Clinical Cancer Research. 20(9). 2350–2362. 44 indexed citations
18.
Cavnar, Michael J., Shan Zeng, Teresa S. Kim, et al.. (2013). KIT oncogene inhibition drives intratumoral macrophage M2 polarization. The Journal of Experimental Medicine. 210(13). 2873–2886. 101 indexed citations
19.
Hess, Ricarda, et al.. (2012). A Novel Approach for In Vitro Studies Applying Electrical Fields to Cell Cultures by Transformer-Like Coupling. Cell Biochemistry and Biophysics. 64(3). 223–232. 14 indexed citations
20.
Hartung, G., W. Queißer, E. Hagmüller, et al.. (1996). Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity. Oncology Research and Treatment. 19(1). 62–67. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026